201 related articles for article (PubMed ID: 23417297)
1. Shigella impairs T lymphocyte dynamics in vivo.
Salgado-Pabón W; Celli S; Arena ET; Nothelfer K; Roux P; Sellge G; Frigimelica E; Bousso P; Sansonetti PJ; Phalipon A
Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4458-63. PubMed ID: 23417297
[TBL] [Abstract][Full Text] [Related]
2. QnAs with Philippe J. Sansonetti.
Gupta S
Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4437. PubMed ID: 23487802
[No Abstract] [Full Text] [Related]
3. Roles for T and NK cells in the innate immune response to Shigella flexneri.
Le-Barillec K; Magalhaes JG; Corcuff E; Thuizat A; Sansonetti PJ; Phalipon A; Di Santo JP
J Immunol; 2005 Aug; 175(3):1735-40. PubMed ID: 16034114
[TBL] [Abstract][Full Text] [Related]
4. The Shigella flexneri type three secretion system effector IpgD inhibits T cell migration by manipulating host phosphoinositide metabolism.
Konradt C; Frigimelica E; Nothelfer K; Puhar A; Salgado-Pabon W; di Bartolo V; Scott-Algara D; Rodrigues CD; Sansonetti PJ; Phalipon A
Cell Host Microbe; 2011 Apr; 9(4):263-72. PubMed ID: 21501826
[TBL] [Abstract][Full Text] [Related]
5. Antigen-specific CD8(+) T cells fail to respond to Shigella flexneri.
Jehl SP; Doling AM; Giddings KS; Phalipon A; Sansonetti PJ; Goldberg MB; Starnbach MN
Infect Immun; 2011 May; 79(5):2021-30. PubMed ID: 21357720
[TBL] [Abstract][Full Text] [Related]
6. B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection.
Nothelfer K; Arena ET; Pinaud L; Neunlist M; Mozeleski B; Belotserkovsky I; Parsot C; Dinadayala P; Burger-Kentischer A; Raqib R; Sansonetti PJ; Phalipon A
J Exp Med; 2014 Jun; 211(6):1215-29. PubMed ID: 24863068
[TBL] [Abstract][Full Text] [Related]
7. Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity.
Sellge G; Magalhaes JG; Konradt C; Fritz JH; Salgado-Pabon W; Eberl G; Bandeira A; Di Santo JP; Sansonetti PJ; Phalipon A
J Immunol; 2010 Feb; 184(4):2076-85. PubMed ID: 20089698
[TBL] [Abstract][Full Text] [Related]
8. New insights into the crosstalk between Shigella and T lymphocytes.
Salgado-Pabón W; Konradt C; Sansonetti PJ; Phalipon A
Trends Microbiol; 2014 Apr; 22(4):192-8. PubMed ID: 24613405
[TBL] [Abstract][Full Text] [Related]
9. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of
Pinaud L; Samassa F; Porat Z; Ferrari ML; Belotserkovsky I; Parsot C; Sansonetti PJ; Campbell-Valois FX; Phalipon A
Proc Natl Acad Sci U S A; 2017 Sep; 114(37):9954-9959. PubMed ID: 28847968
[TBL] [Abstract][Full Text] [Related]
10. IFNγ inhibits the cytosolic replication of Shigella flexneri via the cytoplasmic RNA sensor RIG-I.
Jehl SP; Nogueira CV; Zhang X; Starnbach MN
PLoS Pathog; 2012; 8(8):e1002809. PubMed ID: 22912573
[TBL] [Abstract][Full Text] [Related]
11. Shigella effector IpaH4.5 targets 19S regulatory particle subunit RPN13 in the 26S proteasome to dampen cytotoxic T lymphocyte activation.
Otsubo R; Mimuro H; Ashida H; Hamazaki J; Murata S; Sasakawa C
Cell Microbiol; 2019 Mar; 21(3):e12974. PubMed ID: 30414351
[TBL] [Abstract][Full Text] [Related]
12. Outer membrane protein A (OmpA) of Shigella flexneri 2a links innate and adaptive immunity in a TLR2-dependent manner and involvement of IL-12 and nitric oxide.
Pore D; Mahata N; Chakrabarti MK
J Biol Chem; 2012 Apr; 287(15):12589-601. PubMed ID: 22343631
[TBL] [Abstract][Full Text] [Related]
13. Shigella flexneri infection in Caenorhabditis elegans: cytopathological examination and identification of host responses.
George DT; Behm CA; Hall DH; Mathesius U; Rug M; Nguyen KC; Verma NK
PLoS One; 2014; 9(9):e106085. PubMed ID: 25187942
[TBL] [Abstract][Full Text] [Related]
14. OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence.
Zurawski DV; Mitsuhata C; Mumy KL; McCormick BA; Maurelli AT
Infect Immun; 2006 Oct; 74(10):5964-76. PubMed ID: 16988276
[TBL] [Abstract][Full Text] [Related]
15.
Schnupf P; Sansonetti PJ
Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 30953429
[No Abstract] [Full Text] [Related]
16.
Willis AR; Torraca V; Gomes MC; Shelley J; Mazon-Moya M; Filloux A; Lo Celso C; Mostowy S
mBio; 2018 Jun; 9(3):. PubMed ID: 29946048
[TBL] [Abstract][Full Text] [Related]
17. Outer membrane protein A (OmpA) from Shigella flexneri 2a: a promising subunit vaccine candidate.
Pore D; Chakrabarti MK
Vaccine; 2013 Aug; 31(36):3644-50. PubMed ID: 23764536
[TBL] [Abstract][Full Text] [Related]
18. Glycan-Glycan Interaction Determines
Belotserkovsky I; Brunner K; Pinaud L; Rouvinski A; Dellarole M; Baron B; Dubey G; Samassa F; Parsot C; Sansonetti P; Phalipon A
mBio; 2018 Feb; 9(1):. PubMed ID: 29440574
[TBL] [Abstract][Full Text] [Related]
19. Septins restrict inflammation and protect zebrafish larvae from Shigella infection.
Mazon-Moya MJ; Willis AR; Torraca V; Boucontet L; Shenoy AR; Colucci-Guyon E; Mostowy S
PLoS Pathog; 2017 Jun; 13(6):e1006467. PubMed ID: 28650995
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic JNK-MAPK pathway involvement requires daf-16-mediated immune response during Shigella flexneri infection in C. elegans.
Marudhupandiyan S; Balamurugan K
Immunol Res; 2017 Jun; 65(3):609-621. PubMed ID: 27838822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
